Sodium-Glucose Cotransporter-2 Inhibitors Across the Glycemic Spectrum: Cardiovascular and Renal Outcomes With Mechanistic Insights CureusSGLT2 Inhibitors: Electrolyte, Water Balance, and Stone Prevention Benefits Beyond Metabolic Effects FrontiersWhat are Benefits and Risks of SGLT2 Inhibitors in Diabetic Kidney Disease? Medical Dialogues
